CLINICAL AND PATHOPHYSIOLOGICAL ASPECTS OF VIRAL HEPATITI
Article Sidebar
Main Article Content
Abstract
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.World Health Organization. (2022). Global progress report on HIV, viral hepatitis and sexually transmitted infections. WHO Press.
2.Terrault, N. A., Lok, A. S., McMahon, B. J., Chang, K. M., Hwang, J. P., et al. (2018). Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 guidance. Hepatology, 67(4), 1560–1599.
3.Pawlotsky, J. M. (2016). Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens. Gastroenterology, 151(1), 70–86.
4.Ringehan, M., McKeating, J. A., & Protzer, U. (2017). Viral hepatitis and liver cancer. Philosophical Transactions of the Royal Society B: Biological Sciences, 372(1732), 20160274.
5.Polaris Observatory Collaborators. (2022). Global prevalence and genotype distribution of hepatitis C virus infection. The Lancet Gastroenterology & Hepatology, 7(8), 724–735.